Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
As of close of business last night, Transmedics Group Inc’s stock clocked out at $167.07, down -1.89% from its previous closing price of $170.28. In other words, the price has decreased by -$1.89 from its previous closing price. On the day, 0.56 million shares were traded. TMDX stock price reached its highest trading level at $175.731 during the session, while it also had its lowest trading level at $166.46.
Ratios:
To gain a deeper understanding of TMDX’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 8.48 and its Current Ratio is at 9.37. In the meantime, Its Debt-to-Equity ratio is 2.72 whereas as Long-Term Debt/Eq ratio is at 2.71.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Cantor Fitzgerald on June 06, 2024, initiated with a Overweight rating and assigned the stock a target price of $161.
On June 04, 2024, Stephens started tracking the stock assigning a Overweight rating and target price of $151.
On March 28, 2024, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $95.Piper Sandler initiated its Overweight rating on March 28, 2024, with a $95 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Aug 15 ’24 when Hassanein Waleed H sold 8,625 shares for $169.73 per share. The transaction valued at 1,463,919 led to the insider holds 61,643 shares of the business.
Waleed H. Hassanein bought 25,875 shares of TMDX for $4,219,695 on Aug 15 ’24. On Aug 07 ’24, another insider, Ranganath Anil P., who serves as the insider of the company, sold 4,289 shares for $152.20 each. As a result, the insider received 652,786 and left with 8,893 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TMDX now has a Market Capitalization of 5672758784 and an Enterprise Value of 5726923776. As of this moment, Transmedics’s Price-to-Earnings (P/E) ratio for their current fiscal year is 4679.69, and their Forward P/E ratio for the next fiscal year is 90.20. For the stock, the TTM Price-to-Sale (P/S) ratio is 15.53 while its Price-to-Book (P/B) ratio in mrq is 29.31. Its current Enterprise Value per Revenue stands at 15.963 whereas that against EBITDA is 133.782.
Stock Price History:
Over the past 52 weeks, TMDX has reached a high of $173.41, while it has fallen to a 52-week low of $36.42. The 50-Day Moving Average of the stock is 12.77%, while the 200-Day Moving Average is calculated to be 62.44%.
Shares Statistics:
It appears that TMDX traded 759.55K shares on average per day over the past three months and 875010 shares per day over the past ten days. A total of 32.67M shares are outstanding, with a floating share count of 32.17M. Insiders hold about 3.56% of the company’s shares, while institutions hold 102.95% stake in the company. Shares short for TMDX as of 1722384000 were 5745628 with a Short Ratio of 7.56, compared to 1719532800 on 6001733. Therefore, it implies a Short% of Shares Outstanding of 5745628 and a Short% of Float of 21.01.
